Papillary thyroid carcinoma and infammation

Frontiers in Endocrinology

Volumn 2, Issue DEC, 2011, Pages

  Fugazzola, Laura ^a   Colombo, Carla ^a   Perrino, Michela ^a   Muzza, Marina ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874380647     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00088     Document Type: Note

References (57)

1. Balkwill, F., and Mantovani, A. (2001). Infammation and cancer: back to Virchow? Lancet 357, 539-545.
2. Barakate, M. S., Agarwal, G., Reeve, T. S., Barraclough, B., Robinson, B., and Delbridge, L. W. (2002). Total thyroidectomy is now the preferred option for the surgical management of Graves disease. Aust. N. Z. J. Surg. 72, 321-324.
3. Behar, R., Arganini, M., Wu, T. C., McCormick, M., Straus, F. H., DeGroot, L. J., and Kaplan, E. L. (1986). Graves disease and thyroid cancer. Surgery 100, 1121-1127.
4. Belfore, A., Garofalo, M. R., Giuffrida, D., Runello, F., Filetti, S., Fiumara, A., Ippolito, O., and Vigneri, R. (1990). Increased aggressiveness of thyroid cancer in patients with Graves disease. J. Clin. Endocrinol. Metab. 70, 830-835.
5. Boostrom, S., and Richards, M. L. (2007). Total thyroid-ectomy is the preferred treatment for patients with Graves disease and a thyroid nodule. Otolaryngol. Head Neck Surg. 136, 278-281.
6. Borrello, M. G., Alberti, L., Ischer, A., Deglinnocenti, D., Ferrario, C., Gariboldi, M., Marchesi, F., Allavena, P., Greco, A., Collini, P., Pilotti, S., Cassinelli, G., Bressan, P., Fugazzola, L., Mantovani, A., and Pierotti, M. A. (2005). Induction of proinfammatory program in normal human thyrocytes by the RET/PTC1 onco-gene. Proc. Natl. Acad. Sci. U.S.A. 102, 14825-14830.
7. Borrello, M. G., DeglInnocenti, D., and Pierotti, M. (2008). Inflammation and cancer: the oncogene-driven connection. Cancer Lett. 267, 262-270.
8. Bradley, E. L., and Liechty, R. D. (1983). Modifed subtotal thyroidectomy for Graves disease: a two-institution study. Surgery 94, 955.
9. Cantalamessa, L., Baldini, M., Orsatti, A., Meroni, L., Amodei, V., and Castagnone, D. (1999). Thyroid nodules in Graves disease and the risk of thyroid carcinoma. Arch. Intern. Med. 159, 1705-1708.
10. Cappelli, C., Braga, M., De Martino, E., Castellano, M., Gandossi, E., Agosti, B., Cumetti, D., Pirola, I., Mattanza, C., Cherubini, L., and Agabati Rosei, E. (2006). Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy. Surg. Today 36, 125-130.
11. Carnell, N. E., and Valente, W. A. (1998). Thyroid nodules in Graves disease: classifcation, characterization, and response to treatment. Thyroid 8, 647-652.
12. Chou, F. F., Sheen-Chen, S. M., Chen, Y. S., and Chen, M. J. (1993). Hyperthyroidism and concurrent thyroid cancer. Int. Surg. 78, 343-346.
13. Coussens, L. M., and Werb, Z. (2002). Infammation and cancer. Nature 420, 860-867.
14. Dobyns, B. M., Sheline, G. E., Workman, J. B., Tompkins, E. A., McConahey, W. M., and Becker, D. V. (1974). Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J. Clin. Endocrinol. Metab. 38, 976-998.
15. Farbota, L. M., Calandra, D. B., Lawrence, A. M., and Paloyan, E. (1985). Thyroid carcinoma in Graves disease. Surgery 98, 1148-1153.
16. Fiore, E., Rago, T., Latrofa, F., Provenzale, M. A., Piaggi, P., Delitala, A., Scutari, M., Basolo, F., Di Coscio, G., Grasso, L., Pinchera, A., and Vitti, P. (2011). Hashimotos thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr. Relat. Cancer 18, 429-437.
17. Gabriele, R., Letizia, C., Borghese, M., De Toma, G., Celi, M., Izzo, L., and Cavallaro, A. (2003). Thyroid cancer in patients with hyperthyroidism. Horm. Res. 60, 79-83.
18. Gupta, S., Patel, A., Folstad, A., Fenton, C., Dinauer, C. A., Tuttle, R. M., Conran, R., and Francis, G. L. (2001). Infltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J. Clin. Endocrinol. Metab. 86, 1346-1354.
19. Hales, I. B., McElduff, A., Crummer, P., Clifton-Bligh, P., Delbridge, L., Hoschl, R., Poole, A., Reeve, T. S., Wilmshurst, E., and Wiseman, J. (1992). Does Graves disease or thyrotoxicosis affect the prognosis of thyroid cancer? J. Clin. Endocrinol. Metab. 75, 886-889.
20. Hancock, B. W., Bing, R. F., Dirmikis, S. M., Munro, D. S., and Neal, F. E. (1977). Thyroid carcinoma and concurrent hyperthyroidism - A study of ten patients. Cancer 39, 298-302.
21. Kasuga, Y., Sugenoya, A., Kobayashi, S., Kaneko, G., Masuda, H., Fujimori, M., and Iida, F. (1990). Clinical evaluation of the response to surgical treatment of Graves disease. Surg. Gynecol. Obstet. 170, 327.
22. Kebebew, E., Treseler, P., and Ituarte, C. (2001). Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J. Surg. 25, 632-637.
23. Kim, W. B., Han, S. M., Kim, T. Y., Nam-Goong, S. II, Gong, G., Lee, H. K., Hong, S. J., and Shong, Y. K. (2004). Ultrasonographic screening for detection of thyroid cancer in patients with Graves disease. Clin. Endocrinol. 60, 719-725.
24. Kraimps, J. L., Bouin-Pineau, M. H., Maréchaud, R., and Barbier, J. (1998). Graves disease and thyroid nodules, a not exceptional association. Ann. Chir. 52, 449-451.
25. Kraimps, J. L., Bouin-Pineau, M. H., Mathonnet, M., De Calan, L., Ronceray, J., Visset, J., Marechaud, R., and Barbier., J. (2000). Multicentre study of thyroid nodules in patients with Graves disease. Br. J. Surg. 87, 764-775.
26. Larson, S., Jackson, L., Riall, T., Uchida, T., Thomas, R., Qiu, S., and Evers, B. (2007). Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J. Am. Coll. Surg. 204, 764-775.
27. Lin, C. H., Chiang, F. Y., and Wang, L. F. (2003). Prevalence of thyroid cancer in hyperthyroidism treated by sur-g e r y. Kaohsiung J. Med. Sci. 19, 379-384.
28. Linos, D. A., Karakitsos, D., and Papademetriou, J. (1997). Should the primary treatment of hyperthyroidism be surgical? Eur. J. Surg. 163, 651.
29. Loh, K. C., Greenspan, F. S., Dong, F., Miller, T. R., and Yeo, P. P. B. (1999). Infuence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 84, 458-462.
30. Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008). Cancer-related inflammation. Nature 54, 436-444.
31. Matsubasyashi, S., Kawai, K., Matsumoto, Y., Mukuta, T., Morita, T., Hirai, K., Matsukuza, F., Kakudoh, K., Kuma, K., and Tamai, H. (1995). The correlation between papillary thyroid carcinoma and lym-phocytic infltration in the thyroid gland. J. Clin. Endocrinol. Metab. 80, 3421-3424.
32. Melillo, R. M., Castellone, M. D., Guarino, V., De Falco, V., Cirafci, A., Salvatore, G., Caiazzo, F., Basolo, F., Giannini, R., Kruhoffer, M., Orntoft, T., Fusco, A., and Santoro, M. (2005). The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J. Clin. Invest. 115, 1068-1081.
33. Melliere, D., Etienne, G., and Becquemin, J. P. (1988). Operation for hyperthyroidism: methods and rationale. Am. J. Surg. 155, 395-399.
34. Miccoli, P., Vitti, P., Rago, T., Iacconi, P., Bartalena, L., Bogazzi, F., Fiore, E., Valeriano, R., Chiovato, L., Rocchi, R., and Pinchera, A. (1996). Surgical treatment of Graves disease: subtotal or total thyroidectomy? Surgery 120, 1020-1024.
35. Mssrouri, R., Benamr, S., Esadel, A., Mdaghri, J., Mohammadine el, H., Lahlou, M. K., Taghy, A., Belmahi, A., and Chad, B. (2008). Thyroid cancer in patients with Graves disease. J. Chir. (Paris) 145, 244-246.
36. Muzza, M., DeglInnocenti, D., Colombo, C., Perrino, M., Ravasi, E., Rossi, S., Cirello, V., Beck-Peccoz, P., Borrello, M. G., and Fugazzola, L. (2010). The tight relationship between papillary thyroid cancer, auto-immunity and infammation: clinical and molecular studies. Clin. Endocrinol. 72, 702-708.
37. Ohmori, N., Miyakawa, M., Ohmori, K., and Takano, K. (2007). Ultrasonographic fndings of papillary thyroid carcinoma with Hashimotos thyroiditis. Intern. Med. 46, 547-550.
38. Ozaki, O., Ito, K., Kobayashi, K., Toshima, K., Iwasaki, H., and Yashiro, T. (1990). Thyroid carcinoma in Graves disease. World J. Surg. 14, 437-440.
39. Ozoux, J. P., de Calan, L., Portier, G., Rivallain, B., Favre, J. P., Robier, A., Goga, D., and Brizon, J. (1988). Surgical treatment of Graves disease. Am. J. Surg. 156, 177-181.
40. Pacini, F., Elisei, R., Di Coscio, G. C., Anelli, S., Macchia, E., Concetti, R., Miccoli, P., Arganini, M., and Pinchera, A. (1988). Thyroid carcinoma in thyro-toxic patients treated by surgery. J. Endocrinol. Invest. 11, 107-112.
41. Pellegriti, G., Belfore, A., Giuffrida, D., Lupo, L., and Vigneri, R. (1998). Outcome of differentiated thyroid cancer in Graves patients. J. Clin. Endocrinol. Metab. 83, 2805-2809.
42. Phitayakorn, R., and McHenry, C. R. (2008). Incidental thyroid carcinoma in patients with Graves disease. Am. J. Surg. 195, 292-297.
43. Pino Rivero, V., Guerra Camacho, M., Marcos García, M., Trinidad Ruiz, G., Pardo Romero, G., González Palomino, A., and Blasco Huelva, A. (2004). The incidence of thyroid carcinoma in Hashimotos thy-roiditis. Our experience and literature review. An Otorrinolaringol. Ibero Am. 31, 223-230.
44. Pomorski, L., Cywiński, J., and Rybiński, K. (1996). Cancer in hyperthyroidism. Neoplasma 43, 217-219.
45. Puxeddu, E., Knauf, J. A., Sartor, M. A., Castellone, M. D., Santoro, M., and Rothstein, J. L. (2005). RET/PTC induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response. Endocr. Relat. Cancer 12, 319-334.
46. Razack, M. S., Lore, J. M., Lippes, H. A., Schaefer, D. P., and Rassael, H. (1997). Total thyroidectomy for Graves disease. Head Neck 19, 378-383.
47. Rieger, R., Pimpl, W., Money, S., Rettenbacher, L., and Galvan, G. (1989). Hyperthyroidism and concurrent thyroid malignancies. Surgery 106, 6-10.
48. Russel, J. P., Shinoara, S., Melillo, R. M., Castellone, M. D., Santoro, M., and Rothstein, J. L. (2003). Tyrosine kinase oncoprotein, RET/PTC3, indices the secretion of myeloid growth and chemotactic factors. Oncogene 22, 4569-4577.
49. Ryder, M., Ghossein, R. A., Ricarte-Filho, J. C., Knauf, J. A., and Fagin, J. A. (2008). Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr. Relat. Cancer 15, 1069-1074.
50. Shapiro, S. J., Friedman, N. B., Perzik, S. L., and Catz, B. (1970). Incidence of thyroid carcinoma in Graves disease. Cancer 26, 1261-1270.
51. Tamimi, D. M. (2002). The association between chronic lymphocytic thyroiditis and thyroid tumors. Int. J. Surg. Pathol. 10, 14-16.
52. Terzioǧlu, T., Tezelman, S., Onaran, Y., and Tanakol, R. (1993). Concurrent hyperthyroidism and thyroid carcinoma. Br. J. Surg. 80, 1301-1302.
53. Wahl, R. A., Goretzki, P., Meybier, H., Nitschke, J., Linder, M., and Röher, H. D. (1982). Coexistence of hy per thy-roidism and thyroid cancer. World J. Surg. 6, 385-390.
54. Weber, K. J., Solorzano, C. C., Lee, J. K., Gaffud, M. J., and Prinz, R. A. (2006). Thyroidectomy remains an effective treatment option for Graves disease. Am. J. Surg. 191, 400-405.
55. Yano, Y., Shibuya, H., Kitagawa, W., Nagahama, M., Sugino, K., Ito, K., and Ito, K. (2007). Recent outcome of Graves disease patients with papillary thyroid cancer. Eur. J. Endocrinol. 157, 325-329.
56. Zanella, E., Rulli, F., Sianesi, M., Sciacchitano, S., Danese, D., Pontecorvi, A., and Farinon, A. M. (2001). Hyperthyroidism with concurrent thyroid cancer. Ann. Ital. Chir. 72, 293-297.
57. Zivaljević, V. R., Diklić, A. D., Krović, K. L., Zorić, G. V., Zivić, R. V., Kalezić, N. K., Kazić, M. T., Tatić, S. B., Havelka, M. J., and Paunović, I. R. (2008). The incidence rate of thyroid microcarcinoma during surgery benign disease. Acta Chir. Iuglos. 55, 69-73.